Dermatofibrosarcoma protuberans (DFSP) is a relatively unusual fibrohistiocytic tumor that is classified as an intermediate-grade malignancy [1, 2] . DFSP is characterized by infiltrative growth and a high propensity for local recurrence after surgical excision [1] [2] [3] [4] . Despite its locally aggressive behavior, DFSP has little metastatic potential [1] [2] [3] [4] , and when distant metastasis does occur, it almost always arises after repeated local recurrences and usually involves lung, bone, or locoregional lymph nodes [1, 3, 4] . The authors report a rare case of a DFSP that metastasized to the lung without any preceding local recurrence.
A 32-year-old otherwise healthy woman presented with a 1 × 1 cm sized, well-circumscribed, skincolored maculopapular lesion of one year's duration on the anterior aspect of her right thigh. Histopathologically, the excised tumor was composed of spindleshaped cells, which were positive for CD34 and were arranged in a storiform pattern (Fig. 1A) . Focal fibrosarcomatous changes presented in a herringbone pattern and were associated with CD34 negativity (Fig. 1B) . Cellularity and mitotic activity were much higher (10/HPF) in the fibrosarcomatous than in the DFSP areas. No distant metastasis was detected preoperatively by pelvic computed tomography or positron emission tomography (PET). Wide excision with a 3-cm free margin, including the deep fascial layer, was performed; the resulting defect was recon- structed with a fasciocutaneous flap. Subsequently, regular evaluations were undertaken for local recurrence and distant metastasis. Three years after surgery, PET computed tomography (CT) was performed for a routine evaluation of recurrence and metastasis, without any symptoms or signs. Multiple pulmonary nodules were found on PET CT and a subsquent lung CT scan revealed the same results (Fig. 2) . The CT-guided biopsy specimen of the lung was histopathologically and immunohistochemically identical to the tumor previously resected from the thigh (Fig. 3 ). These findings resulted in a diagnosis of metastasis. Subsequently, the patient was treated with multiple chemotherapeutic agents, including adriamycin, dacarbazine, and ifosfamide. Four years after the metastasis was discovered, there was no evidence of disease progression and and the disease exhibited stability.
DFSP is a fibrohistiocytic tumor of intermediategrade malignancy with locally aggressive and infiltrative capabilities [1] [2] [3] [4] . It has an incidence of only 3-6.5 cases per million persons per year, and usually arises during early to middle age [4] . DFSP is typically found on the trunk, proximal extremities, head, and neck, but may present at almost any site [1, 2] . Furthermore, DFSP is characterized by a high propensity for local recurrence. According to previous articles, about 11% to 53% of affected patients experience relapse after adequate wide excision, and the local recurrence rate was affected by the depth of disease invasion, site of disease, high mitotic activity, microscopically close resection margin, and increased cellularity [5] . However, despite this high frequency of local recurrence, metastasis only occurs in less than 6% of cases [4] . Metastasis mostly occurs after repeated local recurrences and most commonly in lung, bone, and locoregional lymph nodes [1, 3, 4] . On the other hand, distant metastasis without local recurrence is rare; our review of the literature revealed only three other reported cases [1] [2] [3] . Systemic evaluation is needed for the early diagnosis and proper management of patients with distant metastasis in the absence of local recurrence.
A more hostile subtype of DFSP presents with fibrosarcomatous transformation, and is called 'fibrosarcomatous dermatofibrosarcoma (FS-DFSP)' [1, 4] . Regions of fibrosarcomatous progression are characterized by a herringbone growth pattern, dense cellularity, a greater proportion of atypical cells, large cell sizes, and increased mitotic activity [4] . Furthermore, FS-DFSP shows remarkably diminished or absent CD34 immunoreactivity [1, 4] . This condition is considered a progressed form of DFSP with increased metastatic potential [1, 4] , and it has been reported that old age, dense cellularity, high mitotic index (more than 10 mitotic figures/HPF), a microscopically close resection margin, and specific histopathologic subtypes, such as, FS-DFSP, have a poor prognosis [1] . These findings caution that more careful local and systemic evaluations are needed in patients with a history of hostile histopathologic results, especially in cases of FS-DFSP.
Although DFSP has little metastatic potential, and it almost always arises after repeated local recurrences, we suggest that more careful local and systemic evaluations are needed for the early diagnosis and proper management of patients with distant metastasis in the absence of local recurrence, especially in cases of more hostile histopathologic results. complications ten years after the injection. A number of articles have reported complications of PAAG injection for aesthetic purposes, but it was difficult to find any Korean reports on complications that have occurred as long as ten years after breast augmentation with PAAG. The patient presented with breast lumps, which had developed six months earlier. The lumps were palpable in two locations: at the upper outer part of the right breast and at the center of the chest between the breasts. The patient had undergone filler injection for breast augmentation ten years earlier at a local clinic in Shenyang, China. The patient only remembered a filler material called Amazingel was used, but did not recall the quantity of the material injected. Through a tracing investigation, we determined that Amazingel was a PAAG-type of filler material manufactured in China. During physical examination, symptoms such as tenderness and a burning sensation were not observed around the lumps, and there was no discomfort other than contour abnormalities resulting from the lumps. A preoperative magnetic resonance imaging (MRI) scan revealed fluid-filled sacs in the retroglandular areas of both breasts, and part of the contents appeared to have leaked out of the capsules (Fig. 1) . The MRI images showed filler material with a low signal on T1 weighted images and a high signal on T2 weighted images. PAAG consists of a large quantity of water and has a tendency to appear dark in T1 weighted images and bright in T2 weighted images [1] .
The author performed breast implant removal surgery under general anesthesia. Two stab incisions were made in the inframammary folds of the breasts, and dissections were made below the mammary glands. A yellow, granular jelly-like substance was drawn out by breaking off the fibrous capsules (Fig. 2) . The foreign substance was extirpated as much as possible by canCurrently, the most commonly used injection fillers are broadly classified into hyaluronic acid-based absorbable fillers and semi-permanent fillers. Polyacrylamide hydrogel (PAAG) is classified as a semipermanent filler and is manufactured under diverse brands including Aquamid, Bio-alcamid, Interfall, Outline, Formacryl, Bioformacryl, Argiform, and Amagingel. 
